New Brunswick, NJ (August 17, 2020) -- Johnson & Johnson (NYSE: JNJ) will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, September 9th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 10:40 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately two hours after the live webcast.